BCAX
Price
$23.23
Change
+$0.31 (+1.35%)
Updated
Jun 18 closing price
Capitalization
1.53B
58 days until earnings call
Intraday BUY SELL Signals
VSTM
Price
$4.12
Change
-$0.05 (-1.20%)
Updated
Jun 18 closing price
Capitalization
362.04M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs VSTM

BCAX vs VSTM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCAX vs. VSTM commentary
Jun 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2026
Stock price -- (BCAX: $23.23 vs. VSTM: $4.12)
Brand notoriety: BCAX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 359% vs. VSTM: 201%
Market capitalization -- BCAX: $1.53B vs. VSTM: $362.04M
BCAX [@Biotechnology] is valued at $1.53B. VSTM’s [@Biotechnology] market capitalization is $362.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 5 TA indicator(s) are bullish while VSTM’s TA Score has 6 bullish TA indicator(s).

  • BCAX’s TA Score: 5 bullish, 5 bearish.
  • VSTM’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а +9.16% price change this week, while VSTM (@Biotechnology) price change was +4.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

VSTM is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAX($1.53B) has a higher market cap than VSTM($362M). BCAX YTD gains are higher at: 38.027 vs. VSTM (-46.632). BCAX has higher annual earnings (EBITDA): -173.93M vs. VSTM (-191.63M). BCAX has more cash in the bank: 540M vs. VSTM (182M). BCAX has less debt than VSTM: BCAX (1.44M) vs VSTM (85.5M). VSTM has higher revenues than BCAX: VSTM (49.6M) vs BCAX (0).
BCAXVSTMBCAX / VSTM
Capitalization1.53B362M422%
EBITDA-173.93M-191.63M91%
Gain YTD38.027-46.632-82%
P/E Ratio3.41N/A-
Revenue049.6M-
Total Cash540M182M297%
Total Debt1.44M85.5M2%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXVSTM
RSI
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
VSTM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMTM42.501.04
+2.51%
MarketDesk Focused U.S. Momentum ETF
AFGE15.930.04
+0.25%
American Financial Group
DHF2.40N/A
N/A
BNY Mellon High Yield Strategies Fund
SHUS50.19N/A
N/A
Stratified LargeCap Hedged ETF
ECH40.66-0.35
-0.85%
iShares MSCI Chile ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
+1.35%
CLDX - BCAX
46%
Loosely correlated
-1.52%
PCVX - BCAX
46%
Loosely correlated
+1.52%
BCYC - BCAX
45%
Loosely correlated
-0.99%
RCUS - BCAX
43%
Loosely correlated
+0.79%
VYGR - BCAX
42%
Loosely correlated
+2.76%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-1.20%
MDGL - VSTM
37%
Loosely correlated
+1.18%
DYN - VSTM
36%
Loosely correlated
+3.12%
LXEO - VSTM
35%
Loosely correlated
-1.00%
ZYME - VSTM
34%
Loosely correlated
N/A
BCAX - VSTM
33%
Loosely correlated
+1.35%
More